A study presented at last month’s American College of Cardiology meeting indicates that an ultrasound contrast agent under development by Acusphere of Cambridge, MA, could be used in a continuous mode. Imaging continuously with AI-700 could
A study presented at last months American College of Cardiology meeting indicates that an ultrasound contrast agent under development by Acusphere of Cambridge, MA, could be used in a continuous mode. Imaging continuously with AI-700 could help clinicians overcome some of the shortcomings of other agents, which have short persistence times because their contrast-enhancing microbubbles break up under ultrasound beams. Acusphere believes that the AI-700 microbubbles may have longer persistence times because they are made from synthetic polymers. AI-700 is in phase I clinical trials.
Multicenter Study Identifies Key Factors Associated with Mammogram-Occult Ipsilateral Breast Cancer
October 9th 2024A symptomatic first breast cancer diagnosis, prevailing breast density at a second breast cancer diagnosis and trabecular thickening on surveillance mammography were linked to mammogram-occult ipsilateral breast cancer, according to new research.
Can Innovations with AI Help Address the Impact of Staffing Shortages on Radiology Workflow?
October 7th 2024While staffing shortages in radiology continue to persist after the COVID-19 pandemic, current and emerging innovations powered by artificial intelligence (AI) may help facilities navigate these challenges and mitigate rising costs of health care.